Header image

Session K: Hepatitis C risk and prevention

Tracks
Track 3
Thursday, September 12, 2019
11:15 AM - 12:15 PM
Montreal A & B, Level 11

Speaker

Mr Emmanuel Fortier
Doctoral Candidate
CHUM Research Centre

ASSOCIATION BETWEEN SHORT-TERM HOUSING PATTERNS AND HEPATITIS C ACQUISITION: FINDINGS FROM A COHORT OF PEOPLE WHO INJECT DRUGS IN MONTRÉAL, CANADA

11:15 AM - 11:30 AM

Abstract

Speaker Presentation

Video Recording

Biography

Emmanuel Fortier is a psychiatry resident at University of Ottawa and a doctoral candidate at Université de Montréal. His research activities are conducted at the CHUM Research Centre (Montréal) and focus on the epidemiology of drug injecting and HCV. He is supervised by Prof. Julie Bruneau and Prof. Jason Grebely.
Ms Andreea Adelina Artenie
Phd Candidate
University Of Montreal

DIVERSITY OF DETENTION PATTERNS AMONG PEOPLE WHO INJECT DRUGS AND THE ASSOCIATED RISK WITH INCIDENT HEPATITIS C VIRUS (HCV) INFECTION: IMPLICATIONS FOR HCV PREVENTION

11:30 AM - 11:45 AM

Abstract

Video Recording

Biography

Adelina is a PhD candidate studying epidemiology and public health at the University of Montreal. Her research focus is the epidemiology of HCV transmission among people who inject drugs and the impact of prevention strategies in this population group.
Dr Hannah Fraser
Senior Research Associate In Infectious Disease Mathematical Modelling
University Of Bristol

Modelling the impact of prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania

11:45 AM - 12:00 PM

Abstract

Biography

Hannah Fraser has been working on dynamic transmission modelling of HCV and HIV among key populations for the past 5 years, particularly focussing on what scale-up of interventions is needed to achieve HCV elimination among PWID.
Dr. Marina Kornilova
Senior Project Manager Capacity Building And Surveillance
Alliance For Public Health

HIV AND HCV AMONG PEOPLE WHO INJECT DRUGS IN UKRAINE: A STABILIZATION OR A CALM BEFORE THE STORM?

12:00 PM - 12:05 PM

Abstract

Speaker Presentation

Video Recording

Biography

Medical Doctor with a clinical background in HIV/AIDS and viral hepatitis, have more than 10 years of the professional experience in conducting research among key populations, monitoring and evaluation of the public health interventions focused on HIV and viral hepatitis prevention, treatment and care for KP.
Dr Marie Jauffret-Roustide
Research Fellow
INSERM

HCV AMONG PEOPLE WHO INJECT DRUGS IN FRANCE: ACTING ON RISK ENVIRONMENT IN AN EVOLVING CRISIS

12:05 PM - 12:10 PM

Abstract

Speaker Presentation

Biography

Marie Jauffret-Roustide is a Sociologist, Research Fellow at Inserm in France. Her research focuses mainly on harm reduction policies including HCV, migration, and gender issues in drug policies; as well as users' involvement in harm reduction. She has coordinated evaluative intervention studies among vulnerable populations, using a community-based research approach.
Mrs. Alexandra Almeida
Researcher
SDSU/UCSD/FIOCRUZ

THE BRAZILIAN SYNDEMICS OF CRACK USE, HIV AND HCV

12:10 PM - 12:15 PM

Abstract

Speaker Presentation

Biography

Alexandra Almeida holds bachelors and master’s degrees from top universities in Brazil in applied statistics. She recently completed her PhD in Epidemiology and is a PhD student in Substance Use in SDSU. Since 2015 she has worked as a statistician at FIOCRUZ and has taught courses in biostatistics.

Chair

Hannah Fraser
Senior Research Associate In Infectious Disease Mathematical Modelling
University Of Bristol

Behzad Hajarizadeh
Senior Lecturer
UNSW Sydney

loading